| Ytd | -24.44% | |
| 1y | -24.44% |
| Open | 8.51 | Prev Close | 8.35 | Low | 8.33 | High | 8.94 | Mkt Cap | 10.98M |
| Vol | 37.43K | Avg Vol | 55.30K | EPS | -1.36 | P/E | -6.26 | Forward P/E | N/A |
| Beta | 1.53 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 7.20 | 200-d Avg | 7.60 | 1yr Est | 0.00 |
MSLE News
HC Wainwright & Co. analyst Arthur He maintains Satellos Bioscience (NASDAQ:MSLE) with a Buy
Recently listed, Satellos Bioscience Inc. (NASDAQ:MSLE) on Wednesday reported six-month interim data
Satellos reports six-month interim data showing SAT-3247 improved muscle composition, maintained str
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 55.8% to $1.11 during Wednesday'
Fat fraction mean improvement of 3.7% from 49.7% at TRAILHEAD baseline to 46.0% at month 6, suggesti
Satellos Bioscience Inc. (NASDAQ:MSLE, TSX:MSCL) ("Satellos" or the "Company"), a cl
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Sate
TORONTO, May 27, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) ("Satel
Pre-Market Stock Futures: Futures are trading mixed as we get ready to kick off the first-quarter ea
Top Wall Street analysts changed outlook on top names. For all analyst rating changes, see analyst r